Patient advocates reporting from EHA Congress 2011 (Update)
On 9-12 June 2011, the European Hematology Association (EHA) held its 16th Annual Congress in London, featuring newest results from clinical trials and biology research in hematology. Several patient advocates attended the meeting. This year brought great news to the CML patient community - not only from a medical perspective. Jana Pelouchová and Jan Geissler chaired a very successful "Patient Advocates Session" on Adherence within scientific program of the congress, which featured Giora Sharf's presentation of brand-new data of the CML Advocates Network's pilot survey on adherence. In addition, patient advocates from 8 pan-European hematology patient organisations, including the CML Advocates Network, had a very fruitful meeting with EHA's executive board, potentially laying the base for a fruitful cooperation in upcoming years.
Read Updated first line data of Nilotinib, Dasatinib and Bosutinib presented at EHA 2011 (Jan Geissler, 16 June 2011)
Read Stopping CML therapies and eradicating CML: Patient perspective from EHA (Jan Geissler, 16 June 2011)
Read CML Society of Canada's Reports from the EHA Sessions (Cheryl-Anne Simoneau)
Webcasts of CML Experts at EHA 2011
New! Watch Hagop Kantarjian (MD Anderson) on TKI Therapy in CML
New! Watch Giuseppe Saglio on Dasatinib CML data presented at EHA
Watch Tim Hughes, Adelaide, Australia, on Second generation TKIs in chronic myeloid leukaemia (eCancer)
Blogposts about CML at EHA 2011
Patient advocacy session at European Hematology Association EHA 2011 Congress shows impact of drug adherence on outcome (Pieter Droppert / @3NT)
Webcasts of EHA Education Sessions are well worth watching (Pieter Droppert / @3NT, 14 June 2011)
Presentations
Files - for CML Advocates Network Members only
Word file: Selected CML Abstracts of EHA 2011, all in a single document
Slides: Giora Sharf: Adherence: Are You Sure your Patients Are taking Their medicines
Slides: Schoberberger: Compliance Diagnosis and Drug Packaging
Slides: Adherence - David Marin presenting at Patient Advocacvy Session
Updated Abstract: Delphine Rea - StopTKI study - Updated Abstract (with updated results presented at the session)
Thank you for this excellent work !
see you soon
best
Mina
Thank you very much for your reports!
It's great!
All the best,
Stan